Z08.2 ICD-10-CA code: Follow-up examination after chemotherapy for malignant neoplasm

Z08.2 is the ICD-10-CA code for “Follow-up examination after chemotherapy for malignant neoplasm” in CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026.

Official description

Z08.2

Follow-up examination after chemotherapy for malignant neoplasm

Short description: F/U exam after chemo for malgt neoplasm

ICD-10-CA · Canada · Also written Z082

Index terms

Entries in CIHI’s alphabetical index that lead to Z08.2. Searching the index by the condition the note names is how coders reach this code.

  • Examination (general) (routine) (of) (for), following, treatment (for), malignant neoplasm, chemotherapy
  • Examination (general) (routine) (of) (for), follow up (routine) (following), malignant neoplasm, chemotherapy
  • Examination (general) (routine) (of) (for), follow up (routine) (following), chemotherapy NEC, malignant neoplasm
  • Admission (for), follow up examination or routine surveillance after treatment of (for), malignant neoplasm (by) (subsequent to), chemotherapy

Notes for Z08.2

As CIHI prints them, with any note Z08.2 takes from the headings above it.

Includes

Excludes

Conditions classified elsewhere.

Note

  • Nonspecific abnormal findings disclosed at the time of these examinations are classified to categories (R70-R94).From Z00-Z13 Persons encountering health services for examination and investigation
  • This chapter should not be used for international comparison or for primary mortality coding.Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as "diagnoses" or "problems". This can arise in two main ways:(a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination or to discuss a problem which is in itself not a disease or injury.(b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury. Such factors may be elicited during population surveys, when the person may or may not be currently sick, or be recorded as an additional factor to be borne in mind when the person is receiving care for some illness or injury.From Chapter 21: Factors influencing health status and contact with health services (Z00-Z99)

Where Z08.2 sits

  1. 1ChapterChapter 21: Factors influencing health status and contact with health services (Z00-Z99)
  2. 2Block Z00-Z13Persons encountering health services for examination and investigation
  3. 3Category Z08Follow-up examination after treatment for malignant neoplasm
  4. 4Valid code Z08.2Follow-up examination after chemotherapy for malignant neoplasm

Source and release

Data release
ICD-10-CA · FY 2026–2027
Effective date
Apr 1, 2026
Publisher
CIHI

This page is built from the ICD-10-CA catalog that Vero Codes reads when it suggests codes: Canadian Institute for Health Information’s FY 2026–2027 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does ICD-10-CA code Z08.2 mean?

Z08.2 is the ICD-10-CA code for “Follow-up examination after chemotherapy for malignant neoplasm” in CIHI’s ICD-10-CA FY 2026–2027 release.

Where is Z08.2 in ICD-10-CA?

Z08.2 sits under Z08 Follow-up examination after treatment for malignant neoplasm, within Z00-Z13 Persons encountering health services for examination and investigation, within Chapter 21: Factors influencing health status and contact with health services (Z00-Z99).

What coding notes apply to Z08.2?

ICD-10-CA lists Excludes, Includes, Note notes for Z08.2, including those from the headings it sits under. They are listed on this page with where each one comes from.

Which ICD-10-CA release does this page use?

It uses CIHI’s FY 2026–2027 release, in effect from Apr 1, 2026 to Mar 31, 2027. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.